• See Now, Act Now

    See Now, Act Now

    We help health practitioners and patients get
    rapid information for critical decisions
    when it matters most.

  • Designing Revolutionary Rapid Blood Testing Diagnostics,

    Designing Revolutionary Rapid Blood Testing Diagnostics,
    For Revolutionary Rapid
    Front-Lines Medical Decisions.

  • Simplify real-time blood <br />
testing, for everyone, <br />
everywhere.

    Simplify real-time blood
    testing, for everyone,
    everywhere.

See Now.
Act Now.

We help practitioners and patients get rapid information for critical decisions when they matter most.

The Mission

PixCell is transforming blood testing

The HemoScreen platform can perform highly complex tests, currently confined to high-end labs, in a simple, portable instrument. Making such tests extremely accessible will enable early detection of the most critical health issues and thus save lives.

The Product

  • HemoScreen™

    Making the most common blood test simple and accessible anywhere

The test takes 5 minutes and can be performed by virtually anyone.

It includes 3 simple steps:

1 Draw Blood Sample

2 Insert Sample into Cartridge

3 Insert Cartridge into Reader

  • Smart Disposable
    Cartridge

    Ensures sample preparation is automatic and includes all necessary reagents.

  • The Technology

    PixCell’s technology harnesses microfluidics, Lab-On-A-Cartridge and AI to solve a decades old problem. The method employs a new physical phenomenon: Viscoelastic Focusing that causes cells to focus as they flow facilitating their optical analysis.

In the Pipeline: Machine Vision, AI and Microfluidics unravel new diagnostic capabilities

Applying Machine Vision, AI and Lab-On-A-Cartridge to in-vitro diagnostics make the HemoScreen™ a versatile platform that makes heart failure, cancer and infection-related assays easily accessible.

Awards & Recognition

  • HemoScreen Receives FDA 510(k) Clearance making it the first Cartridge Base True Point of Care Hematology Analyzer that brings critical tests to the doctor’s office

  • PixCell had been awarded $3M by the European Innovation Commission to expedite the HemoScreen commercialization and disrupt the POC Hematology diagnostics market

  • The HemoScreen receives CE mark for use in the European Union.

  • PixCell’s HemoScreen has been selected for display at the Israel Innovation Expo first cohort at the Peres Center for Innovation and Peace

  • HemoScreen Receives FDA 510(k) Clearance making it the first Cartridge Base True Point of Care Hematology Analyzer that brings critical tests to the doctor’s office

  • PixCell had been awarded $3M by the European Innovation Commission to expedite the HemoScreen commercialization and disrupt the POC Hematology diagnostics market

  • The HemoScreen receives CE mark for use in the European Union.

  • PixCell’s HemoScreen has been selected for display at the Israel Innovation Expo first cohort at the Peres Center for Innovation and Peace

Clearance & Certifications

Dev by RNCode | Design by Adi